---
figid: PMC11092657__nihpp-2024.05.01.592016v1-f0004
pmcid: PMC11092657
image_filename: PMC11092657__nihpp-2024.05.01.592016v1-f0004.jpg
figure_link: /pmc/articles/PMC11092657/figure/FFigure 4./
number: Figure 4.
figure_title: VGLL2-NCOA2 and TEAD1-NCOA2 engage p300 epigenetic regulators
caption: A. Diagram showing the BioID proteomic analyses of BirA*-VGLL2-NCOA2, BirA*-TEAD1-NCOA2,
  BirA*-YAP5SA, and BirA*-TAZ4SA.B. Co-IP assay showing endogenous p300 binding to
  VGLL2-NCOA2 and TEAD1-NCOA2 but not YAP5SA.C. KEGG enrichment analysis of p300 CUT&RUN
  peaks in control HEK293T cells and HEK293T cells expressing VGLL2-NCOA2 or TEAD1-NCOA2.
  The “Hippo signaling pathway” highlighted in red.D. Motif enrichment analysis of
  p300 CUT&RUN peaks in control HEK293T cells and HEK293T cells expressing VGLL2-NCOA2
  or TEAD1-NCOA2.E. Genomic tracks showing p300 occupancy at the CYR61, ANKRD1, CTGF,
  and CREB3 loci in control HEK293T cells and HEK293T cells expressing VGLL2-NCOA2
  or TEAD1-NCOA2
article_title: VGLL2 and TEAD1 fusion proteins drive YAP/TAZ-independent transcription
  and tumorigenesis by engaging p300
citation: Susu Guo, et al. bioRxiv. 2024 May 03;NA(NA).
year: '2024'
pub_date: 2024-5-03
epub_date: 2024-5-03
doi: 10.1101/2024.05.01.592016
journal_title: bioRxiv
journa_nlm_ta: bioRxiv
publisher_name: Cold Spring Harbor Laboratory
keywords:
- VGLL2
- TEAD1
- NCOA2
- fusion
- Hippo signaling pathway
- p300
---
